Skip links

News

personalizing-lifestyle-interventions-for-cancer-survivors

Personalizing lifestyle interventions for cancer survivors

MIAMI, FLORIDA (Jan. 10, 2024) – Researchers with Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have received funding to better understand how personalized nutrition and exercise programs can improve quality of life after cancer treatment. Credit: Photo by Sylvester
one-more-step-toward-treatment-of-parp-inhibitor-resistant-ovarian-cancers

One more step toward treatment of PARP inhibitor-resistant ovarian cancers

“This initiative is geared towards identifying additional biomarkers that can aid in selecting the most appropriate treatments for ovarian cancer.” Credit: 2023 Ray et al. “This initiative is geared towards identifying additional biomarkers that can aid in selecting the most appropriate treatments for ovarian cancer.”
blood-test-distinguishes-neuroendocrine-subtype-of-advanced-prostate-cancer

Blood test distinguishes neuroendocrine subtype of advanced prostate cancer

Boston – Like a criminal entering a witness protection program, cancer cells can shed their past and take on a new identity. Detecting such an identity-switch is particularly challenging when metastatic castration-resistant prostate cancer (CRPC) advances from adenocarcinoma to neuroendocrine prostate cancer (NEPC), a very
new-nih-funded-center-could-soon-reduce-the-need-for-pharmaceutical-trials-on-animals

New NIH-funded center could soon reduce the need for pharmaceutical trials on animals

The University of Rochester will house a new national center focused on using tissue-on-chip technology to develop drugs more rapidly and reduce the need for animal trials. The National Institutes of Health awarded a $7.5 million grant to establish the Translational Center for Barrier Microphysiological Systems (TraCe-bMPS) at Rochester
using-chatbots-to-advance-spanish-speaking-patient-outreach

Using chatbots to advance Spanish-speaking patient outreach

In her latest study, Kim Kaphingst, ScD, director of cancer communication research at Huntsman Cancer Institute and professor of communications at the University of Utah, is using chatbots to reach Spanish-speaking patients and teach them about genetic testing.  Credit: Huntsman Cancer Institute In her latest
Explore
Drag